| Primary |
| Diabetes Mellitus |
52.5% |
| Diabetes Mellitus Insulin-dependent |
27.5% |
| Diabetes |
5.0% |
| Hyperglycaemia |
5.0% |
| Type 2 Diabetes Mellitus |
5.0% |
| Diabetes Mellitus Non-insulin-dependent |
2.5% |
| Type 1 Diabetes Mellitus |
2.5% |
|
| Hypoglycaemia |
19.6% |
| Mental Status Changes |
13.0% |
| Loss Of Consciousness |
10.9% |
| Syncope |
8.7% |
| Hyperhidrosis |
6.5% |
| Blood Glucose Decreased |
4.3% |
| Medication Error |
4.3% |
| Treatment Noncompliance |
4.3% |
| Unresponsive To Stimuli |
4.3% |
| Accidental Overdose |
2.2% |
| Inadequate Diet |
2.2% |
| Inappropriate Schedule Of Drug Administration |
2.2% |
| Lethargy |
2.2% |
| Malaise |
2.2% |
| Pancreatitis |
2.2% |
| Rash |
2.2% |
| Somnolence |
2.2% |
| Tremor |
2.2% |
| Vomiting |
2.2% |
| Wrong Technique In Drug Usage Process |
2.2% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
41.2% |
| Diabetes Mellitus |
15.8% |
| Product Used For Unknown Indication |
6.9% |
| Hypertension |
6.3% |
| Drug Use For Unknown Indication |
3.9% |
| Schizophrenia |
3.6% |
| Type 1 Diabetes Mellitus |
3.6% |
| Asthma |
3.3% |
| Diabetes Mellitus Non-insulin-dependent |
2.7% |
| B Precursor Type Acute Leukaemia |
2.4% |
| Hypertensive Cardiomyopathy |
1.8% |
| Blood Pressure |
1.2% |
| Diabetes Mellitus Insulin-dependent |
1.2% |
| Hypocalcaemia |
1.2% |
| Angina Pectoris |
0.9% |
| Dyspnoea |
0.9% |
| Hypercholesterolaemia |
0.9% |
| Pain |
0.9% |
| Skin Ulcer |
0.9% |
| Abdominal Pain |
0.6% |
|
| Glycosylated Haemoglobin Increased |
12.1% |
| Pancreatitis |
9.1% |
| Pancreatitis Acute |
7.6% |
| Renal Failure Acute |
7.6% |
| Respiratory Arrest |
7.6% |
| Tremor |
6.1% |
| Hypoglycaemia |
4.5% |
| Hypoglycaemic Encephalopathy |
4.5% |
| Oesophageal Candidiasis |
4.5% |
| Pneumonia |
4.5% |
| Thrombocytopenia |
4.5% |
| Blood Glucose Increased |
3.0% |
| Haemothorax |
3.0% |
| Hypokalaemia |
3.0% |
| Infection |
3.0% |
| Nausea |
3.0% |
| Obesity |
3.0% |
| Opportunistic Infection |
3.0% |
| Renal Failure |
3.0% |
| Retroperitoneal Neoplasm |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.6% |
| Drug Use For Unknown Indication |
17.3% |
| Diabetes Mellitus |
13.4% |
| Hypertension |
8.3% |
| Type 2 Diabetes Mellitus |
4.8% |
| Pain |
3.3% |
| Diabetes Mellitus Non-insulin-dependent |
3.0% |
| Prophylaxis |
3.0% |
| Rheumatoid Arthritis |
2.2% |
| Nuclear Magnetic Resonance Imaging |
2.2% |
| Depression |
2.2% |
| Osteoporosis |
2.0% |
| Anxiety |
1.5% |
| Type 1 Diabetes Mellitus |
1.4% |
| Asthma |
1.4% |
| Coronary Artery Bypass |
1.2% |
| Imaging Procedure |
1.1% |
| Nausea |
1.1% |
| Cardiac Disorder |
1.0% |
| Thrombosis Prophylaxis |
1.0% |
|
| Weight Decreased |
16.3% |
| Vomiting |
14.3% |
| Blood Glucose Increased |
7.6% |
| Wheezing |
5.8% |
| Nausea |
5.4% |
| Urinary Tract Infection |
4.7% |
| Myocardial Infarction |
4.5% |
| Syncope |
4.5% |
| Pain |
4.3% |
| Renal Failure Acute |
4.3% |
| Renal Failure |
3.6% |
| Weight Increased |
3.1% |
| Wrong Technique In Drug Usage Process |
3.1% |
| Dyspnoea |
2.9% |
| Hypoglycaemia |
2.9% |
| Skin Tightness |
2.9% |
| Somnolence |
2.7% |
| Pneumonia |
2.5% |
| Staphylococcal Bacteraemia |
2.5% |
| Death |
2.2% |
|
